Beta Drugs Ltd PE Ratio

Beta Drugs PE Ratio

Image

Beta Drugs Ltd

NSE: BETA

PE

62.2

Last updated on: Aug 13, 2026

Key Highlights

  • The P/E Ratio of Beta Drugs Ltd is 62.2 as of 13 Aug 13:29 PM The P/E Ratio of Beta Drugs Ltd changed from 9.8 on March 2021 to 45.3 on March 2025 . This represents a CAGR of 35.82% over 5 years The Latest Trading Price of Beta Drugs Ltd is ₹ 2582 as of 13 Aug 13:09 The PE Ratio of Pharmaceuticals Industry has changed from 24.6 to 32.5 in 5 years. This represents a CAGR of 5.73% The PE Ratio of Automobile industry is 12.4. The PE Ratio of Finance industry is 16.4. The PE Ratio of IT - Software industry is 18.4. The PE Ratio of Pharmaceuticals industry is 31.9. The PE Ratio of Retail industry is 91.5. The PE Ratio of Textiles industry is 37.5 in 2026 .

Historical P/E Ratio of Beta Drugs Ltd

No data available

Company Fundamentals for Beta Drugs Ltd

Image

Beta Drugs Ltd

NSE: BETA

Share Price

₹ 2582.3

23.30 (0.91%)

stock direction

Last updated on: Aug 13, 2026

Market Price of Beta Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Beta Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Aug 20262559
11 Aug 20262668.3
10 Aug 20262504
07 Aug 20262373.7
06 Aug 20262518.9
05 Aug 20262366.9
04 Aug 20262365
03 Aug 20262353
31 Jul 20262231.9
30 Jul 20262203.4

SWOT Analysis Of Beta Drugs Ltd

Strength

3

che

Weakness

2

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Beta Drugs Ltd

Asset Value vs Market Value of Beta Drugs Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Beta Drugs Ltd2836
Sun Pharmaceutical Industries Ltd464271
Divis Laboratories Ltd226843
Torrent Pharmaceuticals Ltd186000
Zydus Lifesciences Ltd120099
Cipla Ltd118071

PE Ratio of Beta Drugs Ltd Explained

2836

Market cap

45

Earnings

62.2X

PE Ratio

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Beta Drugs Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Beta Drugs Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Beta Drugs Ltd

No data available

* All values are in %

About Beta Drugs Ltd

  • Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005.
  • Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017 Beta Drugs is a part of Adley Group.
  • Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India.
  • The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
  • The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.

Beta Drugs Ltd News Hub

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 15 May 2025. Powered by C

Read more

10 May 25

Beta Drugs schedules AGM

Beta Drugs announced that the 19th Annual General Meeting (AGM) of the company will be held on 30 Se

Read more

02 Sept 24

Beta Drugs to conduct EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 12

Read more

21 Oct 24

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 6 November 2024 Powered b

Read more

04 Nov 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Beta Drugs Ltd

What is the current PE Ratio of Beta Drugs Ltd?

The Current PE Ratio of Beta Drugs Ltd is 62.23 as on 13 Aug 2026.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 31.9 as on 13 Aug 2026.

What was the PE Ratio of Beta Drugs Ltd last year?

The PE Ratio of Beta Drugs Ltd was 32.55 last year, now the PE ratio is 62.23, showing a year-on-year growth of 91.2%.

What does the PE Ratio of Beta Drugs Ltd indicate about its stock?

The PE Ratio of Beta Drugs Ltd is 62.23. This ratio indicates that investors are willing to pay 62.23 times the earnings per share for each share of Beta Drugs Ltd.

What is the PE Ratio Growth of Beta Drugs Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Beta Drugs Ltd grew by 91.2% whereas, the EPS ratio grew by 65.5.

How does the PE ratio of Beta Drugs Ltd compare to industry peers?

The PE ratio of Beta Drugs Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Beta Drugs Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Beta Drugs Ltd PE Ratio.

What factors influence the PE ratio of Beta Drugs Ltd PE Ratio?

The PE ratio of Beta Drugs Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Beta Drugs Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Beta Drugs Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Beta Drugs Ltd PE Ratio?

You can check the latest PE ratio of Beta Drugs Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Beta Drugs Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Beta Drugs Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Beta Drugs Ltd PE Ratio predict future stock performance?

While the Beta Drugs Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions